Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 17161048)

Published in Am Heart J on December 01, 2006

Authors

Jing Fang1, George A Mensah, Michael H Alderman, Janet B Croft

Author Affiliations

1: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341-3717, USA. jfang@cdc.gov

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

State of disparities in cardiovascular health in the United States. Circulation (2005) 9.32

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03

Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol (2008) 5.65

Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke (2005) 5.18

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60

Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation (2006) 3.93

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation (2008) 3.56

Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation (2003) 3.39

Sodium intake and mortality in the NHANES II follow-up study. Am J Med (2006) 3.24

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 3.10

The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99

The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int (2004) 2.96

Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med (2009) 2.81

Adverse childhood experiences and personal alcohol abuse as an adult. Addict Behav (2002) 2.68

Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation (2003) 2.61

NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. Am J Respir Crit Care Med (2015) 2.60

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med (2004) 2.52

American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation (2003) 2.49

Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ (2009) 2.35

Adverse childhood experiences and the risk of premature mortality. Am J Prev Med (2009) 2.31

Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest (2015) 2.29

Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease. Circulation (2006) 2.20

Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise. Stroke (2002) 2.14

Factors explaining excess stroke prevalence in the US Stroke Belt. Stroke (2009) 2.09

When chronic conditions become acute: prevention and control of chronic diseases and adverse health outcomes during natural disasters. Prev Chronic Dis (2005) 2.03

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med (2009) 2.02

World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation (2002) 2.02

COPD surveillance--United States, 1999-2011. Chest (2013) 1.92

Pulmonary hypertension surveillance--United States, 1980-2002. MMWR Surveill Summ (2005) 1.91

Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84

Low public recognition of major stroke symptoms. Am J Prev Med (2003) 1.84

Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med (2008) 1.79

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2006) 1.73

Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med (2015) 1.70

A call for higher standards of evidence for dietary guidelines. Am J Prev Med (2008) 1.69

Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol (2009) 1.67

Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. Stroke (2004) 1.66

Acute myocardial infarction hospitalization in the United States, 1979 to 2005. Am J Med (2010) 1.63

Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol (2002) 1.63

Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke (2002) 1.62

Disparities in cardiac care: rising to the challenge of Healthy People 2010. J Am Coll Cardiol (2004) 1.59

Relationships between hours of sleep and health-risk behaviors in US adolescent students. Prev Med (2011) 1.59

Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. Am J Hypertens (2013) 1.57

Hypertension control at physicians' offices in the United States. Am J Hypertens (2008) 1.56

Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens (2005) 1.55

Overreporting of deaths from coronary heart disease in New York City hospitals, 2003. Prev Chronic Dis (2010) 1.54

Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension (2005) 1.53

Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999. Arch Intern Med (2004) 1.47

Evidence-based approach for disaster preparedness authorities to inform the contents of repositories for prescription medications for chronic disease management and control. Prehosp Disaster Med (2009) 1.46

Racial differences in the use of aspirin: an important tool for preventing heart disease and stroke. Ethn Dis (2005) 1.46

Adverse childhood experiences are associated with the risk of lung cancer: a prospective cohort study. BMC Public Health (2010) 1.44

Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest (2013) 1.44

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation (2004) 1.44

High blood pressure: the foundation for epidemic cardiovascular disease in African populations. Ethn Dis (2003) 1.44

Disparities in chronic disease risk factors and health status between American Indian/Alaska Native and White elders: findings from a telephone survey, 2001 and 2002. Am J Public Health (2005) 1.42

Co-occurrence of leading lifestyle-related chronic conditions among adults in the United States, 2002-2009. Prev Chronic Dis (2013) 1.40

Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000. Am Heart J (2005) 1.39

Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation (2006) 1.39

Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Prev Med (2005) 1.37

Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2013) 1.32

Associations between short- and long-term unemployment and frequent mental distress among a national sample of men and women. J Occup Environ Med (2003) 1.31

A legal framework for preventing cardiovascular diseases. Am J Prev Med (2005) 1.30

Screening and assessment of coronary heart disease in HIV-infected patients. Circulation (2008) 1.29

Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28

Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients. Am J Hypertens (2011) 1.27

Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart (2012) 1.26

Trends in hospitalization with chronic obstructive pulmonary disease-United States, 1990-2005. COPD (2010) 1.26

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. Circulation (2004) 1.25

Public recognition of major signs and symptoms of heart attack: seventeen states and the US Virgin Islands, 2001. Am Heart J (2004) 1.25

Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med (2010) 1.24

Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke (2006) 1.24